CLINICAL_TRIALS
research
· 2025-02-20
Clinical Trial Update: Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
Summary
A Korean study is evaluating the safety and effectiveness of a triple oral antidiabetic drug therapy for Type 2 diabetes. The sponsor is Chong Kun Dang Pharmace…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Diabetes Mellitus, Type 2 | Status: RECRUITING